Congrats Jordan and Bagrat! Incredibly well deserved
Bioverge is honored to have been a part of this journey, and confident that this is only just the beginning.
Next up: let's bring these engineered tissues and organs to life!
In a deal just announced this week, Bioverge portfolio company Volumetric has entered into an agreement for acquisition by 3D Systems (NASDAQ: DDD).
We could not be more thrilled for the Volumetric team and for participating Bioverge investors on the successful exit!
On the latest podcast, @EricTopol, Founder & Director of @scrippsresearch Translational Inst., sits down with @njlittman to discuss #COVID19#DeltaVariant, why it's such a formidable adversary & what steps need to be taken to combat the ongoing pandemic.
https://t.co/uYapZfyhic
Time to learn a new word: Teravoxel.
2 billion pixels * 100,000 layers is 200 Teravoxels (200 trillion volumetric pixels). And it may be enough to build human organs.
This is one of those layers. In real time.
(STROBE WARNING)
@QwQiao Absolutely- we should all be able to support the causes we care about! @LifespanIO is doing great work on this front. At @biovergehq we are working to democratize access to healthcare investment opportunities with transformative potential
We can all play a role in transforming healthcare. The crowdfunding of emerging healthcare startups and clinical research is perhaps the most direct, measurable, and scalable ways of making an impact
Previous "studies have shown that night owls are as much as twice as likely to suffer from depression as early risers, regardless of how long they sleep."
This is consistent with Octagon's findings. Severe COVID/long COVID resembles an autoantibody-driven autoimmune disease and the same pathological immune cell activation pathway is involved.
We might be about to see an increase in autoimmunity...
https://t.co/jQKUfSQrhd
With the launch of our Reg CF campaign, we’re one step closer to democratizing access to early-stage healthcare investments, learn more and invest below!
Our #equitycrowdfunding campaign is officially live on @netcapital and we've already raised over $136K! 🚀 Effective immediately, you can become a shareholder in Bioverge. Don't miss out on the opportunity 👉 https://t.co/hoyHMvt4qj
Newly launched Bioverge Impact Program & partnership w/ @EpilepsyFdn will support Eysz's Reg CF campaign for dev. of AI-driven digital Epilepsy Management Platform. Portion of our fees will be donated to the EF in support of their mission.
https://t.co/J2Qm8VPPkO